Choksi Laboratories Limited (BOM:526546)
122.95
-5.05 (-3.95%)
At close: Jun 19, 2026
Choksi Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 460.06 | 417.82 | 366.95 | 344.41 | 300.42 | |
Revenue Growth (YoY) | 10.11% | 13.86% | 6.55% | 14.64% | 16.95% |
Cost of Revenue | 274.85 | 200.75 | 171.08 | 155.95 | 139.93 |
Gross Profit | 185.21 | 217.08 | 195.87 | 188.46 | 160.49 |
Selling, General & Admin | - | 5.66 | 6.02 | 5.33 | 3.22 |
Other Operating Expenses | 63.85 | 96.95 | 86.07 | 78.86 | 66.8 |
Operating Expenses | 134.74 | 169.59 | 150.74 | 141.03 | 125.83 |
Operating Income | 50.47 | 47.48 | 45.13 | 47.43 | 34.67 |
Interest Expense | -28.16 | -26.6 | -30.07 | -34.94 | -32.12 |
Interest & Investment Income | 1.75 | 0.6 | 1.64 | 1.97 | 1.16 |
Currency Exchange Gain (Loss) | 0.35 | 0.06 | -0.02 | 0.2 | -0.07 |
Other Non Operating Income (Expenses) | - | - | - | - | -0 |
EBT Excluding Unusual Items | 24.42 | 21.54 | 16.68 | 14.66 | 3.64 |
Gain (Loss) on Sale of Assets | - | -0 | -0.05 | -0.01 | 0.04 |
Other Unusual Items | 7.53 | - | - | 22.56 | - |
Pretax Income | 31.95 | 21.53 | 16.63 | 37.21 | 3.67 |
Income Tax Expense | 12.3 | 6.3 | 5.53 | 5.11 | 1.6 |
Net Income | 19.64 | 15.23 | 11.1 | 32.1 | 2.07 |
Net Income to Common | 19.64 | 15.23 | 11.1 | 32.1 | 2.07 |
Net Income Growth | 28.95% | 37.26% | -65.43% | 1450.73% | - |
Shares Outstanding (Basic) | 7 | 7 | 7 | 7 | 7 |
Shares Outstanding (Diluted) | 7 | 7 | 7 | 7 | 7 |
Shares Change (YoY) | 0.01% | - | - | - | - |
EPS (Basic) | 2.82 | 2.19 | 1.59 | 4.61 | 0.30 |
EPS (Diluted) | 2.82 | 2.19 | 1.59 | 4.61 | 0.30 |
EPS Growth | 28.94% | 37.55% | -65.50% | 1450.73% | - |
Free Cash Flow | -1.13 | 43.39 | 45.47 | 43.01 | 51.98 |
Free Cash Flow Per Share | -0.16 | 6.23 | 6.53 | 6.17 | 7.46 |
Gross Margin | 40.26% | 51.95% | 53.38% | 54.72% | 53.42% |
Operating Margin | 10.97% | 11.36% | 12.30% | 13.77% | 11.54% |
Profit Margin | 4.27% | 3.65% | 3.02% | 9.32% | 0.69% |
Free Cash Flow Margin | -0.24% | 10.38% | 12.39% | 12.49% | 17.30% |
EBITDA | 121.36 | 106.73 | 102.27 | 102.41 | 88.94 |
EBITDA Margin | 26.38% | 25.54% | 27.87% | 29.73% | 29.61% |
D&A For EBITDA | 70.89 | 59.25 | 57.14 | 54.98 | 54.28 |
EBIT | 50.47 | 47.48 | 45.13 | 47.43 | 34.67 |
EBIT Margin | 10.97% | 11.36% | 12.30% | 13.77% | 11.54% |
Effective Tax Rate | 38.51% | 29.26% | 33.27% | 13.74% | 43.60% |
Revenue as Reported | 462.19 | 418.49 | 368.59 | 346.58 | 301.62 |
Advertising Expenses | - | 0.28 | 0.99 | 1.15 | 0.15 |